2. Academic Validation
  3. Design, synthesis, and biological evaluation of novel diphenylmethyl-sulfinyl-bridged bisamides as wakefulness-promoting and anti-fatigue agents

Design, synthesis, and biological evaluation of novel diphenylmethyl-sulfinyl-bridged bisamides as wakefulness-promoting and anti-fatigue agents

  • Eur J Med Chem. 2026 Sep 5:313:118858. doi: 10.1016/j.ejmech.2026.118858.
Haoxin Xiong 1,  Yifan Wu 2,  Yijie Wang 3,  Jing Xu 4,  Lin Wang 4,  Tao Peng 5,  Shuchen Liu 6,  Shouguo Zhang 7
Affiliations

Affiliations

  • 1 School of Pharmacy, Henan University, Kaifeng, Henan, 475004, PR China; Beijing Institute of Radiation Medicine, 27 Taiping Road, Beijing, 100850, PR China. Electronic address: xhx18612132529@163.com.
  • 2 Beijing Institute of Radiation Medicine, 27 Taiping Road, Beijing, 100850, PR China; School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou, 510006, PR China.
  • 3 Guangdong Key Laboratory of Chiral Molecule and Drug Discovery School of Pharmaceutical Sciences Sun Yat-sen University, Guangzhou, 510006, PR China.
  • 4 Beijing Institute of Radiation Medicine, 27 Taiping Road, Beijing, 100850, PR China.
  • 5 Beijing Institute of Radiation Medicine, 27 Taiping Road, Beijing, 100850, PR China. Electronic address: p.tao@tom.com.
  • 6 Beijing Institute of Radiation Medicine, 27 Taiping Road, Beijing, 100850, PR China. Electronic address: liusc118@sohu.com.
  • 7 School of Pharmacy, Henan University, Kaifeng, Henan, 475004, PR China; Beijing Institute of Radiation Medicine, 27 Taiping Road, Beijing, 100850, PR China. Electronic address: zhangshouguo1409@sina.com.
PMID: 42033992 DOI: 10.1016/j.ejmech.2026.118858
Abstract

Narcolepsy severely impairs quality of life, characterized by irresistible sleepiness and persistent fatigue. The first-line agent modafinil (MOD) promotes wakefulness primarily by inhibiting the Dopamine Transporter (DAT), thereby elevating synaptic dopamine levels. In parallel, positive allosteric modulators (PAMs) of the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor enhance glutamatergic transmission, demonstrating notable wakefulness-promoting and anti-fatigue potential. Using MOD as a lead compound and leveraging the crystal structure of the AMPA Receptor together with a homology model of the Dopamine Transporter (DAT), we designed, optimized and synthesized a series of diphenylmethyl-sulfinyl-bridged bisamide derivatives. Their activities were evaluated in vivo, identifying compound B1 as the most promising candidate. B1 significantly prolonged sleep latency and reduced sleep duration in pentobarbital-induced sleep models without increasing spontaneous locomotion. It also extended forced swimming time and rotarod endurance. Furthermore, B1 alleviated behavioral deficits from acute sleep deprivation. Preliminary mechanistic studies indicated that B1 exhibits moderate affinity for the Dopamine Transporter and enhances AMPA receptor-mediated ion currents while delaying channel deactivation, thereby functioning as a positive allosteric modulator. In summary, B1 is a novel and potent wakefulness-promoting and anti-fatigue candidate, supporting its further development as a therapeutic agent for narcolepsy and fatigue-related conditions.

Keywords

AMPA receptor; Anti-fatigue; Dopamine transporter; Modafinil; Wakefulness-promoting.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z